Your browser doesn't support javascript.
loading
Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer.
Stares, M; Ding, T E; Stratton, C; Thomson, F; Baxter, M; Cagney, H; Cumming, K; Swan, A; Ross, F; Barrie, C; Maclennan, K; Campbell, S; Evans, T; Tufail, A; Harrow, S; Lord, H; Laird, B; MacKean, M; Phillips, I.
Afiliación
  • Stares M; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Edinburgh; University of Edinburgh, Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, Western General Hospital, Edinburgh.
  • Ding TE; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Edinburgh.
  • Stratton C; University of Edinburgh, Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, Western General Hospital, Edinburgh.
  • Thomson F; University of Edinburgh, Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, Western General Hospital, Edinburgh.
  • Baxter M; Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee; Tayside Cancer Centre, Ninewells Hospital and Medical School, NHS Tayside, Dundee.
  • Cagney H; School of Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK.
  • Cumming K; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Edinburgh.
  • Swan A; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Edinburgh.
  • Ross F; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Edinburgh.
  • Barrie C; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Edinburgh.
  • Maclennan K; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Edinburgh.
  • Campbell S; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Edinburgh.
  • Evans T; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Edinburgh.
  • Tufail A; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Edinburgh.
  • Harrow S; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Edinburgh.
  • Lord H; Tayside Cancer Centre, Ninewells Hospital and Medical School, NHS Tayside, Dundee.
  • Laird B; University of Edinburgh, Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, Western General Hospital, Edinburgh.
  • MacKean M; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Edinburgh.
  • Phillips I; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Edinburgh; University of Edinburgh, Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, Western General Hospital, Edinburgh. Electronic address: Iain.phillips@nhslothian.scot.nhs.uk.
ESMO Open ; 7(2): 100445, 2022 04.
Article en En | MEDLINE | ID: mdl-35398717
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: ESMO Open Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: ESMO Open Año: 2022 Tipo del documento: Article